Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Archives of Pediatrics & Adolescent Medicine|December 8, 2004
Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP)Lorraine Alexander, Guthrie Birkhead, Fernando Guerra, et al.
The Journal of Infectious Diseases|November 26, 2013
Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012Prabhu P Gounder, Michael G Bruce, Dana J T Bruden, et al.
The Pediatric Infectious Disease Journal|September 25, 2012
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trialRosalyn Singleton, Jay Wenger, Joseph A Klejka, et al.
MMWR. Morbidity and Mortality Weekly Report|November 15, 2019
Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2018-June 2019Jaume Jorba, Ousmane M Diop, Jane Iber, et al.
The Lancet. Infectious Diseases|December 7, 2020
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trialAnanda S Bandyopadhyay, Chris Gast, Luis Rivera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2008
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological BoardJohn Neff, John Modlin, Guthrie S Birkhead, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine ImmunizationClea Sarnquist, Marisa Holubar, Lourdes García-García, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trialsXavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, et al.
The Journal of Infectious Diseases|October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical TrialsChristopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Pageof 4